Cargando…

Correction: Molecular profile of BRCA-mutated biliary tract cancers

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470489/ https://www.ncbi.nlm.nih.gov/pubmed/32878925 http://dx.doi.org/10.1136/esmoopen-2020-000682corr1

Ejemplares similares

Molecular profile of BRCA-mutated biliary tract cancers
por: Spizzo, Gilbert, et al.
Publicado: (2020)

Correction: Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ikejima, Kengo, et al.
Publicado: (2023)

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
por: De Talhouet, Solene, et al.
Publicado: (2020)

Correction to: Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
por: Kim, Hyera, et al.
Publicado: (2020)

Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers
por: Gschwantler-Kaulich, Daphne, et al.
Publicado: (2018)

Correction: The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers
Publicado: (2019)

Correction: BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
por: Alemar, Bárbara, et al.
Publicado: (2018)

Correction: Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases
por: Stavropoulou, Alexandra V., et al.
Publicado: (2013)

Correction: Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes
por: Stefansson, Olafur Andri, et al.
Publicado: (2009)

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
por: Mavaddat, Nasim, et al.
Publicado: (2020)

BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer
por: Nakashima, Shinsuke, et al.
Publicado: (2015)

Correction to: Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review
por: Huber, D., et al.
Publicado: (2021)

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
por: Coignard, Juliette, et al.
Publicado: (2021)

Correction: Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial
por: Yamauchi, Hideko, et al.
Publicado: (2023)

Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy
por: Carter, Philip, et al.
Publicado: (2018)

Correction: Unravelling the Transcriptome Profile of the Swine Respiratory Tract Mycoplasmas
Publicado: (2014)

Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer
por: Spring, Laura M., et al.
Publicado: (2022)

Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer
por: Ahn, Soomin, et al.
Publicado: (2020)

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
por: Gaudet, Mia M., et al.
Publicado: (2010)

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
por: Gaudet, Mia M., et al.
Publicado: (2010)

Author Correction: Physical activity and sleep behaviour in women carrying BRCA1/2 mutations
por: Galasso, Letizia, et al.
Publicado: (2022)

Correction: When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans
por: Wong-Brown, Michelle, et al.
Publicado: (2022)

Correction: The Trouble with Sliding Windows and the Selective Pressure in BRCA1
por: Schmid, Karl, et al.
Publicado: (2008)

Correction: Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
por: MacConaill, Laura E., et al.
Publicado: (2010)

Correction: Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
por: MacConaill, Laura E., et al.
Publicado: (2009)

Correction to: Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain)
por: de Sabando, Ainara Ruiz, et al.
Publicado: (2019)

Correction: A Protein Prioritization Approach Tailored for the FA/BRCA Pathway
por: Haitjema, Anneke, et al.
Publicado: (2013)

Molecular Trajectory of BRCA1 and BRCA2 Mutations
por: Hatano, Yuichiro, et al.
Publicado: (2020)

Correction to: Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
por: Buchanan, Adam H., et al.
Publicado: (2021)

Correction: Gene Expression Profiling of Ampullary Carcinomas Classifies Ampullary Carcinomas into Biliary-Like and Intestinal-Like Subtypes That Are Prognostic of Outcome
por: Overman, Michael J., et al.
Publicado: (2013)

Molecular Profiling in Daily Clinical Practice: Practicalities in Advanced Cholangiocarcinoma and Other Biliary Tract Cancers
por: Lamarca, Angela, et al.
Publicado: (2020)

Austrian tricentric real-life analysis of molecular profiles of metastatic biliary tract cancer patients
por: Taghizadeh, Hossein, et al.
Publicado: (2023)

Germline mutations in cancer-predisposition genes in patients with biliary tract cancer
por: Terashima, Takeshi, et al.
Publicado: (2019)

Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers
por: Rizzolo, Piera, et al.
Publicado: (2018)

Correction: Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining
por: Beckta, Jason M., et al.
Publicado: (2016)

Correction: Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer
Publicado: (2014)

Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
por: Personeni, Nicola, et al.
Publicado: (2020)

Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?
por: Carter, Philip, et al.
Publicado: (2018)

KRAS Mutation as a Potential Prognostic Biomarker of Biliary Tract Cancers
por: Yokoyama, Masaaki, et al.
Publicado: (2016)

Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer
por: Kim, Hongsik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bi369uf021os10te6aj4tbj12n